Clinical Trials Browser

Phase 2 × Lymphoma, Non-Hodgkin × Immune Checkpoint Inhibitors × Clear all

NCT04539444 2021-08-02

A Study of CD19/22 CART Cells Combined With PD-1 Inhibitor in Relapsed/Refractory B-cell Lymphoma

Phase 2 Unknown

Lymphoma, Non-Hodgkin, Recurrence